The data shown below were collected from the profiles of 64 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The emerging role of regulatory cell-based therapy in autoimmune disease
|
|---|---|
| Published in |
Frontiers in immunology, December 2022
|
| DOI | 10.3389/fimmu.2022.1075813 |
| Pubmed ID | |
| Authors |
Farbod Ghobadinezhad, Nasim Ebrahimi, Fatemeh Mozaffari, Neda Moradi, Sheida Beiranvand, Mehran Pournazari, Fatemeh Rezaei-Tazangi, Roya Khorram, Maral Afshinpour, Rob A. Robino, Amir Reza Aref, Leonardo M. R. Ferreira |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 9% |
| United Kingdom | 2 | 3% |
| Comoros | 1 | 2% |
| Egypt | 1 | 2% |
| India | 1 | 2% |
| Spain | 1 | 2% |
| Morocco | 1 | 2% |
| Unknown | 51 | 80% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 69% |
| Scientists | 18 | 28% |
| Practitioners (doctors, other healthcare professionals) | 1 | 2% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 13% |
| Student > Bachelor | 9 | 13% |
| Student > Master | 7 | 10% |
| Student > Ph. D. Student | 4 | 6% |
| Other | 3 | 4% |
| Other | 6 | 9% |
| Unknown | 32 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 7% |
| Immunology and Microbiology | 4 | 6% |
| Nursing and Health Professions | 3 | 4% |
| Other | 9 | 13% |
| Unknown | 32 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2023.
All research outputs
#962,627
of 26,540,415 outputs
Outputs from Frontiers in immunology
#860
of 33,365 outputs
Outputs of similar age
#21,543
of 499,530 outputs
Outputs of similar age from Frontiers in immunology
#27
of 1,674 outputs
Altmetric has tracked 26,540,415 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,365 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 499,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 1,674 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.